AR036797A1 - Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn - Google Patents
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohnInfo
- Publication number
- AR036797A1 AR036797A1 ARP020103823A ARP020103823A AR036797A1 AR 036797 A1 AR036797 A1 AR 036797A1 AR P020103823 A ARP020103823 A AR P020103823A AR P020103823 A ARP020103823 A AR P020103823A AR 036797 A1 AR036797 A1 AR 036797A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- solvent
- granules
- treatment
- binder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Un método para la preparación de gránulos que comprende ácido 5-aminosalicílico (5-ASA) o una sal o éster farmacéuticamente aceptable del mismo y un aglutinante farmacéuticamente aceptable que comprende: (a) disolver el aglutinante farmacéuticamente aceptable en un solvente, (b) mezclar el aglutinante disuelto con 5-ASA para formar una masa húmeda, (c) extruir la masa húmeda en gránulos, y (d) secar los gránulos al evaporarse el solvente, caracterizado porque el solvente está comprendido por al menos el 50% p/p de agua. Reivindicación 18: Un método para la preparación de comprimidos de liberación prolongada, útil para el tratamiento de colitis ulcerosa o enfermedad de Crohn, que comprende los pasos de (a) mezclar ácido 5-aminosalicílico o una sal o éster farmacéuticamente aceptable del mismo y un aglutinante farmacéuticamente aceptable en un solvente que comprende al menos el 50% p/p de agua, y extruir luego la mezcla producida para proveer gránulos al evaporarse el solvente, (b) aplicar sobre dichos gránulos una composición de recubrimiento que comprende una solución de un material de recubrimiento farmacéuticamente aceptable en un solvente orgánico para proveer así gránulos recubiertos al evaporarse el solvente, (c) mezclar los gránulos recubiertos con uno o más excipientes para comprimidos farmacéuticamente aceptables, y (d) formar comprimidos a partir de la mezcla resultante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32883101P | 2001-10-15 | 2001-10-15 | |
PCT/DK2001/000677 WO2003032952A1 (en) | 2001-10-15 | 2001-10-15 | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AR036797A1 true AR036797A1 (es) | 2004-10-06 |
Family
ID=41795791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020103823A AR036797A1 (es) | 2001-10-15 | 2002-10-11 | Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn |
Country Status (4)
Country | Link |
---|---|
US (3) | US8282955B2 (es) |
AR (1) | AR036797A1 (es) |
EG (1) | EG24584A (es) |
MY (1) | MY137570A (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
US20070042143A1 (en) * | 2003-04-23 | 2007-02-22 | Ferring B.V. | Sachet for a pharmaceutical composition |
EP1547601A1 (en) | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
US20090028944A1 (en) * | 2007-07-16 | 2009-01-29 | Balaji Sathurappan | Pharmaceutical compositions comprising mesalamine |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
US9078824B2 (en) * | 2007-09-24 | 2015-07-14 | The Procter & Gamble Company | Composition and method of stabilized sensitive ingredient |
US20090169622A1 (en) * | 2007-12-27 | 2009-07-02 | Roxane Laboratories, Inc. | Delayed-release oral pharmaceutical composition for treatment of colonic disorders |
EP2340812A1 (en) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granules for pharmaceutical preparations, methods and apparatus for their production |
ITUA20162293A1 (it) | 2016-04-05 | 2017-10-05 | Sofar Spa | Processo per formulazioni solide di mesalazina |
US20220125733A1 (en) * | 2020-10-23 | 2022-04-28 | Atoz Pharmaceuticals Pvt Ltd | Nongranulated compressed tablets of mesalamine, and process of preparation thereof |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4638131B1 (es) | 1966-06-22 | 1971-11-10 | ||
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
JPS57500432A (es) * | 1980-03-20 | 1982-03-11 | ||
JPS6048484B2 (ja) | 1980-05-20 | 1985-10-28 | アルザ・コ−ポレ−シヨン | 拡散性活性剤デイスペンサ− |
JPS5758631A (en) | 1980-09-24 | 1982-04-08 | Toyo Jozo Co Ltd | Coating composition |
ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
DE3151196A1 (de) * | 1981-12-23 | 1983-06-30 | Kurt Heinz Prof. Dr. 7800 Freiburg Bauer | Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen |
SE457505B (sv) | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
NL8502178A (nl) | 1984-08-16 | 1986-03-17 | Sandoz Ag | Nieuwe farmaceutische preparaten. |
US5254347A (en) | 1988-03-31 | 1993-10-19 | Tanabe Seiyaku Co., Ltd. | Controlled release pharmaceutical preparation and method for producing the same |
US5194464A (en) | 1988-09-27 | 1993-03-16 | Takeda Chemical Industries, Ltd. | Enteric film and preparatoin thereof |
US5484605A (en) | 1988-11-25 | 1996-01-16 | Henning Berlin Gmbh Chemie-Und Pharmawerk | Agent for treating chronically inflammatory intestinal diseases |
GB8913889D0 (en) | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
IT1246382B (it) | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
GB2253346A (en) | 1991-02-22 | 1992-09-09 | John Rhodes | Delayed release oral dosage forms for treatment of intestinal disorders |
US5316772A (en) | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
GB2256587A (en) | 1991-06-11 | 1992-12-16 | American Cyanamid Co | Acetazolamide in sustained release form |
US5472712A (en) | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5482718A (en) * | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
JPH0826977A (ja) | 1994-07-19 | 1996-01-30 | Tanabe Seiyaku Co Ltd | 溶出制御型経口製剤 |
NZ325201A (en) | 1995-12-21 | 1998-11-25 | Ferring Farma Lab | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
US6004581A (en) * | 1995-12-21 | 1999-12-21 | Farmaceutisk Laboratorium Ferring A/S | Modified release oral pharmaceutical composition and method for the treatment of bowel diseases |
US6245351B1 (en) | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
IL118932A0 (en) | 1996-07-24 | 1996-10-31 | Dexcel Ltd | Controlled release tablets |
EP0930917B1 (en) | 1996-07-28 | 2003-10-15 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
AU5775398A (en) | 1996-12-17 | 1998-07-15 | Poli Industria Chimica S.P.A. | Site-specific controlled release dosage formulation for mesalamine |
GB9722426D0 (en) | 1997-10-23 | 1997-12-24 | Univ London Pharmacy | Controlled release formulations |
CA2332398A1 (en) * | 1998-05-19 | 1999-11-25 | Ian Irwin | Benzamide therapeutics for the treatment of inflammatory bowel disease |
IT1303753B1 (it) | 1998-11-13 | 2001-02-23 | Ct Lab Farm Srl | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. |
ITMI991316A1 (it) | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
JP2001055322A (ja) | 1999-08-18 | 2001-02-27 | Tanabe Seiyaku Co Ltd | パルス放出型製剤 |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
IT1318376B1 (it) | 2000-03-07 | 2003-08-25 | Pharmatec Internat S R L | Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. |
DE10013030A1 (de) | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Verwendung eines Copolymers zur Herstellung einer Arzneiform zur Therapie von Colitis ulcerosa und verwendungsgemäße Arzneiform |
IT1318625B1 (it) | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
US20020177579A1 (en) | 2000-11-06 | 2002-11-28 | Larry Augsburger | Extended release formulation of water-soluble drugs |
US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
AU2003288182A1 (en) | 2002-11-26 | 2004-06-18 | Universiteit Gent | Process and apparatus for continuous wet granulation of power material |
US20070042143A1 (en) | 2003-04-23 | 2007-02-22 | Ferring B.V. | Sachet for a pharmaceutical composition |
EP1547601A1 (en) | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
-
2002
- 2002-10-11 US US10/269,055 patent/US8282955B2/en not_active Expired - Lifetime
- 2002-10-11 AR ARP020103823A patent/AR036797A1/es not_active Application Discontinuation
- 2002-10-14 EG EG2002101118A patent/EG24584A/en active
- 2002-10-14 MY MYPI20023836A patent/MY137570A/en unknown
-
2012
- 2012-09-07 US US13/606,443 patent/US8697135B2/en not_active Expired - Lifetime
-
2013
- 2013-12-19 US US14/133,934 patent/US20140193492A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20130195980A1 (en) | 2013-08-01 |
MY137570A (en) | 2009-02-27 |
US20030138495A1 (en) | 2003-07-24 |
US20140193492A1 (en) | 2014-07-10 |
EG24584A (en) | 2009-11-16 |
US8697135B2 (en) | 2014-04-15 |
US8282955B2 (en) | 2012-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028299A1 (es) | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. | |
KR920703046A (ko) | 경구용 항응고제/혈소판 억제제 저용량 제형 | |
AR036797A1 (es) | Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn | |
ATE30380T1 (de) | Pharmazeutische formulierungen mit mehrfachen einheiten. | |
RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
KR870000920A (ko) | 9-데옥소-11-데옥시-9,11-[이미노[2-(2-메톡시에톡시) 에틸리덴]-옥시]-(9s)-에리트로마이신을 함유하는 경구투여용 고형 약제학적 제제의 제조방법 | |
ATE248589T1 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
ES2079183T3 (es) | Formas de dosificacion oral de liberacion retardada para el tratamiento de trastornos intestinales. | |
ATE266390T1 (de) | Stossweise freisetzende arzneiabgabesysteme | |
JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
ES2331046T1 (es) | Formulacion de liberacion controlada. | |
AR066313A2 (es) | Una formulacion de liberacion controlada de galantamina, una forma farmaceutica de dosificacion, un proceso para la preparacion de dicha formulacion, y el uso de dicha formulacion para la manufactura de un medicamento | |
DK0825858T3 (da) | Flerumættede omega-3-fedtsyrer til behandling af inflammatorisk tarmsygdom i kapsler med tidsafhængig frigivelse | |
KR870003778A (ko) | 신규 약제의 제조방법 | |
WO2000009091A1 (en) | Once daily analgesic tablet | |
KR880002529A (ko) | 혈전증 치료용 약학적 조성물 및 이의 제조방법 | |
RU99107283A (ru) | Не содержащие лактозы, негигроскопичные и безводные фармацевтические препараты дескарбоэтоксилоратадина | |
DE69816951D1 (de) | Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix | |
DE60235648D1 (de) | Pharmazeutische metformintablette mit verlängerter freisetzung | |
EA200001201A3 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
KR930009605A (ko) | 소염 또는 진통제 | |
DE60006362D1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
PL327323A1 (en) | Orally administered 5-asa containing pharmaceutic composition of modified active substance release and method of treating intestinal diseases | |
SE8901003D0 (sv) | Snabbloesliga preparat | |
AR025879A1 (es) | Granulaciones de celulosa hidrolizada de sales de farmacos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |